Cormorant Asset Management »

Ibio shares owned by Cormorant Asset Management

Quarter-by-quarter ownership of Ibio (IBIO) shares owned by Cormorant Asset Management from 13F filings

Historical chart of Cormorant Asset Management investment in Ibio

Tip: Access up to 7 years of quarterly data

All positions including Ibio held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ibio by Cormorant Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $6.2M 3.6M 1.75

More positions owned by Cormorant Asset Management

Praxis Precision Medicines I Com New (PRAX)
Bridgebio Oncology Therapeut Com New (BBOT)
Parabilis Medicines
Rapport Therapeutics (RAPP)
Erasca (ERAS)
Edgewise Therapeutics (EWTX)
Eyepoint Com New (EYPT)
Alumis (ALMS)
Abivax Sa Sponsored Ads (ABVX)
Dianthus Therapeutics (DNTH)
Bright Minds Biosciences Com New (DRUG)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Bioage Labs (BIOA)
Oruka Therapeutics (ORKA)
Adlai Nortye Sponsored Ads (ANL)

View all positions for Cormorant Asset Management

Top funds holding Ibio

Affinity Asset Advisors
Cormorant Asset Management
Silverarc Capital Management
Vestal Point Capital
Vanguard Capital Management
Frazier Life Sciences Management
Ensign Peak Advisors
Woodline Partners
Millennium Management
Citadel Advisors
Balyasny Asset Management
Bank of America Corporation
Ikarian Capital
Sio Capital Management
Marshall Wace

View all funds holding Ibio